Process of Preparation of Quinazoline
This technology is related to process of preparing of 4-(3-chloro -4-fluorophenylamjno)-7-methoxy -6- [3-(4-morpholinyl) propoxy] quinazoline (Gefitinib). What is Novelty? The earlier technologies for preparing 4-(3-chloro-4-fluorophenylamino)-7-methoxy-6-[3-(4-morpholinyl)propoxy]-quinazoline (gefitinib) having low yield about 50% -75% whereas present technology gives high yield. In addition, has significant advantage in terms of time and cost. This technology can produce Gefitinib in less synthetic steps.
Sector: Pharmaceuticals
Country: India
Area of Application: medical industry, pharma industry.
Keywords: Quinazoline,AstraZeneca (Iressa),Teva,NATCO
Advantages: Non-Infringing method of producing Gefitinib. Cost Effective drug. Less production cost. High yield compared to earlier Gefitinib production methods. Huge market opportunity. FDA approval for Gefitinib.
Environmental aspects: Not Applicable
Development Status: Laboratory Model
Legal Protection: Patent in Progress
Technical specifications:
Transfer Terms: Technology Licensing
Target Countries: India
Estimated cost (US$):
Upload any relevant document:
Contact Person: SkyQuest Technology Consulting Pvt. Ltd.
Address: 501, Krishna Complex, Opp. Devashish School, Bodakdev
City: Ahmedabad
Country: India
Zip/Pin Code: 380054